Bayesian Capital Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-2,801
| Closed | -$201K | – | 250 |
|
|
2026
Q1 | $201K | Sell |
2,801
-4,447
| -61% | -$343K | 0.25% | 118 |
|
|
2025
Q4 | $575K | Sell |
7,248
-10,552
| -59% | -$832K | 1.32% | 21 |
|
|
2025
Q3 | $1.34M | Sell |
17,800
-49,700
| -74% | -$3.41M | 0.27% | 112 |
|
|
2025
Q2 | $4.66M | Sell |
67,500
-12,200
| -15% | -$800K | 0.74% | 20 |
|
|
2025
Q1 | $5.4M | Buy |
+79,700
| New | +$4.77M | 0.89% | 15 |
|
|
2024
Q4 | – | Sell |
-61,100
| Closed | -$3.84M | – | 744 |
|
|
2024
Q3 | $3.84M | Buy |
+61,100
| New | +$3.56M | 0.45% | 44 |
|
|
2024
Q1 | – | Sell |
-171,400
| Closed | -$13.5M | – | 837 |
|
|
2023
Q4 | $13.5M | Sell |
171,400
-48,100
| -22% | -$3.42M | 1.44% | 6 |
|
|
2023
Q3 | $15.3M | Buy |
219,500
+172,700
| +369% | +$12.2M | 1.75% | 3 |
|
|
2023
Q2 | $3.24M | Sell |
46,800
-13,279
| -22% | -$945K | 0.35% | 53 |
|
|
2023
Q1 | $4.46M | Buy |
60,079
+24,900
| +71% | +$2.09M | 0.55% | 28 |
|
|
2022
Q4 | $3.28M | Buy |
+35,179
| New | +$3.39M | 0.48% | 23 |
|
|
2022
Q1 | – | Sell |
-3,200
| Closed | -$330K | – | 798 |
|
|
2021
Q4 | $330K | Buy |
+3,200
| New | +$296K | 0.1% | 243 |
|
|
2021
Q2 | – | Sell |
-5,466
| Closed | -$411K | – | 456 |
|
|
2021
Q1 | $411K | Buy |
+5,466
| New | +$398K | 0.09% | 270 |
|
|
2020
Q4 | – | Sell |
-56,300
| Closed | -$3.29M | – | 492 |
|
|
2020
Q3 | $3.29M | Buy |
56,300
+49,200
| +693% | +$3.06M | 0.8% | 15 |
|
|
2020
Q2 | $461K | Sell |
7,100
-16,600
| -70% | -$1.05M | 0.1% | 253 |
|
|
2020
Q1 | $1.41M | Sell |
23,700
-24,400
| -51% | -$1.63M | 0.3% | 72 |
|
|
2019
Q4 | $3.57M | Sell |
48,100
-21,600
| -31% | -$1.52M | 0.61% | 23 |
|
|
2019
Q3 | $4.4M | Buy |
+69,700
| New | +$4.13M | 0.83% | 18 |
|
|
2019
Q1 | – | Sell |
-27,202
| Closed | -$1.78M | – | 591 |
|
|
2018
Q4 | $1.78M | Buy |
27,202
+21,471
| +375% | +$1.6M | 0.36% | 55 |
|
|
2018
Q3 | $451K | Buy |
+5,731
| New | +$410K | 0.07% | 355 |
|
|
2016
Q4 | – | Sell |
-11,067
| Closed | -$985K | – | 614 |
|
|
2016
Q3 | $985K | Buy |
11,067
+4,529
| +69% | +$428K | 0.65% | 22 |
|
|
2016
Q2 | $626K | Buy |
+6,538
| New | +$652K | 0.37% | 83 |
|
Other funds holding CVS
Bayesian Capital Management's CVS Position: Q2 2026 in Review
Bayesian Capital Management sold out of CVS Health (CVS) in Q2 2026, closing a stake of 2,801 shares — an estimated $201K sold.
Bayesian Capital Management first reported a position in CVS in Q2 2016 and held it in 22 quarters. The position peaked at $15.3M in Q3 2023. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Bayesian Capital Management reported no remaining CVS Health position as of Q2 2026 after selling out during the quarter.
- Bayesian Capital Management sold 2,801 CVS Health shares in Q2 2026, an estimated $201K.
- Bayesian Capital Management first reported a position in CVS Health in Q2 2016 and held it in 22 quarters.
- Bayesian Capital Management's CVS Health position peaked at $15.3M in Q3 2023.
- 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Bayesian Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.